GEHC's Revolution Vibe CT system.
GE HealthCare
GE HealthCare (GEHC) has received clearance from the U.S. Food and Drug Administration (FDA) for its Revolution Vibe CT system.
First unveiled at the American College of Cardiology 2025 meeting in March, the system is designed to deliver full-heart clarity in a single beat, even without electrocardiogram tracing, the company said. In addition, the system’s AI-powered workflow can help cut exam time by 50% and double coronary CT angiography capacity, according to the vendor.
Radiologie du Var - ELSAN, a radiology clinic in Ollioules, France, is the first in the world to install the system, GEHC noted.
![Images show the pectoralis muscles of a healthy male individual who never smoked (age, 66 years; height, 178 cm; body mass index [BMI, calculated as weight in kilograms divided by height in meters squared], 28.4; number of cigarette pack-years, 0; forced expiratory volume in 1 second [FEV1], 97.6% predicted; FEV1: forced vital capacity [FVC] ratio, 0.71; pectoralis muscle area [PMA], 59.4 cm2; pectoralis muscle volume [PMV], 764 cm3) and a male individual with a smoking history and chronic obstructive pulmonary disorder (COPD) (age, 66 years; height, 178 cm; BMI, 27.5; number of cigarette pack-years, 43.2, FEV1, 48% predicted; FEV1:FVC, 0.56; PMA, 35 cm2; PMV, 480.8 cm3) from the Canadian Cohort Obstructive Lung Disease (i.e., CanCOLD) study. The CT image is shown in the axial plane. The PMV is automatically extracted using the developed deep learning model and overlayed onto the lungs for visual clarity.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/03/genkin.25LqljVF0y.jpg?auto=format%2Ccompress&crop=focalpoint&dpr=2&fit=crop&h=167&q=70&w=250)
